United Therapeutics Corporation (UTHR)
NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
收市：04:00PM EDT
收市後：
| 前收市價 | 274.67 |
| 開市 | 275.00 |
| 買盤 | 274.97 x 100 |
| 賣出價 | 275.42 x 100 |
| 今日波幅 | 273.83 - 279.98 |
| 52 週波幅 | 204.44 - 279.98 |
| 成交量 | |
| 平均成交量 | 525,783 |
| 市值 | 12.209B |
| Beta 值 (5 年，每月) | 0.54 |
| 市盈率 (最近 12 個月) | 13.01 |
| 每股盈利 (最近 12 個月) | 21.16 |
| 業績公佈日 | 2024年7月31日 - 2024年8月05日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 300.95 |
ZacksAllogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag
Allogene (ALLO) reports drab first-quarter 2024 results. The company secures the development and marketing rights to its CD19 oncology program in Europe.
- Zacks
Insmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates
Insmed (INSM) Q1 earnings beat estimates while sales miss the mark. Management posts positive data readouts from mid-stage studies on its experimental inhalation powder in PH-ILD and PAH indications.
- Zacks
Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates
Iovance (IOVA) reports mixed first-quarter results. Shares gain on encouraging initial demand for the recently-approved melanoma drug Amtagvi in the United States.
